J. Alés‐Martínez

SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)

R. Andrés, T. Ramón Y Cajal, G. Llort, 2019, Clinical and Translational Oncology.

Exemestane for breast-cancer prevention in postmenopausal women.

Karen A Gelmon, Dongsheng Tu, James N Ingle, 2011, The New England journal of medicine.

Randomized, multicenter, crossover phase II trial to compare exemestane (E) vs. anastrozole (A) in postmenopausal patients (pt) with advanced breast cancer (ABC) and positive hormone receptors (HR). Final efficacy analysis of GEICAM 2001-03 study.

J. Mayordomo, I. Álvarez, A. Antón, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Exemestane versus anastrozole as front‐line endocrine therapy in postmenopausal patients with hormone receptor‐positive, advanced breast cancer

A. Ruíz, R. Andrés, A. Llombart-Cussac, 2012, Cancer.

Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain

J. Cubiella, S. Servitja, G. Llort, 2018, Psycho-oncology.

National Cancer Institute of Canada Clinical Trials Group MAP.3 Trial: evaluation of exemestane to prevent breast cancer in postmenopausal women.

R. Chlebowski, J. Ingle, P. Goss, 2007, Clinical breast cancer.

Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)

S. Servitja, R. Andrés, A. Llombart-Cussac, 2020, Breast.

Decreased TcR‐CD3+ T cell numbers in healthy aged humans. Evidence that T cell defects are masked by a reciprocal increase of TcR‐CD3−CD2+ natural killer cells

C. Martínez-A, F. Bonilla, A. De La Hera, 1988, European journal of immunology.

Preventive treatments for breast cancer: recent developments

A. Ruíz, R. Andrés, A. Barnadas, 2014, Clinical and Translational Oncology.

Low dose Gemcitabine plus cisplatin in a weekly-based regimen as salvage therapy for relapsed breast cancer after taxane-anthracycline-containing regimens

J. Alés-Martínez, R. Sánchez-Escribano Morcuende, P. Aramburo González, 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Programmed cell death by bcl‐2‐dependent and independent mechanisms in B lymphoma cells.

L. Ding, G. Núñez, Liyun Ding, 1993, The EMBO journal.

Expansion and clonal deletion of peripheral T cells induced by bacterial superantigen is independent of the interleukin‐2 pathway

G. Kroemer, C. Martínez-A, J. Gonzalo, 1992, European journal of immunology.

SEOM–SERAM–SEMNIM guidelines on the use of functional and molecular imaging techniques in advanced non-small-cell lung cancer

R. Delgado-Bolton, G. Fernández-Pérez, P. Sánchez‐Rovira, 2017, Clinical and Translational Oncology.

Cross‐linking of surface IgM or IgD causes differential biological effects in spite of overlap in tyrosine (de)phosphorylation profile

D. Scott, G. Kroemer, J. Casnellie, 1992, European journal of immunology.

Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study

N. Ascunce, M. Ederra, M. Pollán, 2013, Breast Cancer Research.